

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glucose 6-phosphate metabolic process (GO:0051156) | 8.21207250 |
| 2 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.15689906 |
| 3 | protein carboxylation (GO:0018214) | 6.15689906 |
| 4 | GDP-mannose metabolic process (GO:0019673) | 5.35543658 |
| 5 | DNA unwinding involved in DNA replication (GO:0006268) | 4.87940728 |
| 6 | positive regulation of protein kinase C signaling (GO:0090037) | 4.85772393 |
| 7 | viral transcription (GO:0019083) | 4.72909577 |
| 8 | DNA replication checkpoint (GO:0000076) | 4.57419441 |
| 9 | translational termination (GO:0006415) | 4.51886082 |
| 10 | mannose metabolic process (GO:0006013) | 4.49501980 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.41556386 |
| 12 | ribosomal small subunit assembly (GO:0000028) | 4.28433538 |
| 13 | proline metabolic process (GO:0006560) | 4.19993571 |
| 14 | rRNA catabolic process (GO:0016075) | 4.13440758 |
| 15 | translational elongation (GO:0006414) | 4.13244788 |
| 16 | nephron tubule morphogenesis (GO:0072078) | 4.12871657 |
| 17 | nephron epithelium morphogenesis (GO:0072088) | 4.12871657 |
| 18 | intra-S DNA damage checkpoint (GO:0031573) | 4.03172918 |
| 19 | regulation of cholesterol homeostasis (GO:2000188) | 4.00388921 |
| 20 | maturation of SSU-rRNA (GO:0030490) | 3.91621479 |
| 21 | urea cycle (GO:0000050) | 3.87289406 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 3.85785997 |
| 23 | cellular response to ATP (GO:0071318) | 3.77529944 |
| 24 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.76344968 |
| 25 | ribosomal large subunit biogenesis (GO:0042273) | 3.76041316 |
| 26 | urea metabolic process (GO:0019627) | 3.75067507 |
| 27 | histone-serine phosphorylation (GO:0035404) | 3.73479370 |
| 28 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.71337216 |
| 29 | respiratory tube development (GO:0030323) | 3.70873527 |
| 30 | ribosomal small subunit biogenesis (GO:0042274) | 3.68508004 |
| 31 | regulation of fibrinolysis (GO:0051917) | 3.66554055 |
| 32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.64720338 |
| 33 | lung epithelium development (GO:0060428) | 3.63510682 |
| 34 | diacylglycerol metabolic process (GO:0046339) | 3.63261563 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.63249838 |
| 36 | nuclear pore complex assembly (GO:0051292) | 3.61874114 |
| 37 | regulation of cholesterol metabolic process (GO:0090181) | 3.61708256 |
| 38 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.56629891 |
| 39 | translational initiation (GO:0006413) | 3.56472825 |
| 40 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 3.55263392 |
| 41 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 3.55263392 |
| 42 | cellular protein complex disassembly (GO:0043624) | 3.53769642 |
| 43 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.50018528 |
| 44 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.49366004 |
| 45 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.47799905 |
| 46 | semaphorin-plexin signaling pathway (GO:0071526) | 3.47734639 |
| 47 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.46289043 |
| 48 | DNA strand elongation (GO:0022616) | 3.45998872 |
| 49 | protein complex disassembly (GO:0043241) | 3.43848785 |
| 50 | dosage compensation (GO:0007549) | 3.43223050 |
| 51 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.42664040 |
| 52 | nitrogen cycle metabolic process (GO:0071941) | 3.40983271 |
| 53 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.38324179 |
| 54 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.38324179 |
| 55 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.37225231 |
| 56 | plasma lipoprotein particle assembly (GO:0034377) | 3.36542218 |
| 57 | plasma lipoprotein particle remodeling (GO:0034369) | 3.34663280 |
| 58 | protein-lipid complex remodeling (GO:0034368) | 3.34663280 |
| 59 | macromolecular complex remodeling (GO:0034367) | 3.34663280 |
| 60 | reverse cholesterol transport (GO:0043691) | 3.32934610 |
| 61 | protein targeting to ER (GO:0045047) | 3.32279575 |
| 62 | DNA replication initiation (GO:0006270) | 3.31224078 |
| 63 | positive regulation of synapse maturation (GO:0090129) | 3.31091789 |
| 64 | viral life cycle (GO:0019058) | 3.30031351 |
| 65 | cotranslational protein targeting to membrane (GO:0006613) | 3.29855042 |
| 66 | IMP biosynthetic process (GO:0006188) | 3.26008865 |
| 67 | ncRNA 3-end processing (GO:0043628) | 3.24961440 |
| 68 | complement activation, alternative pathway (GO:0006957) | 3.24250394 |
| 69 | regulation of skeletal muscle contraction (GO:0014819) | 3.23871583 |
| 70 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.21459668 |
| 71 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.21459668 |
| 72 | negative regulation of cholesterol transport (GO:0032375) | 3.20126560 |
| 73 | negative regulation of sterol transport (GO:0032372) | 3.20126560 |
| 74 | macromolecular complex disassembly (GO:0032984) | 3.19847359 |
| 75 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.18204490 |
| 76 | negative regulation of fibrinolysis (GO:0051918) | 3.17081301 |
| 77 | plasma lipoprotein particle organization (GO:0071827) | 3.16827196 |
| 78 | cell-cell junction maintenance (GO:0045217) | 3.15756493 |
| 79 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.15161743 |
| 80 | peptidyl-lysine dimethylation (GO:0018027) | 3.13421652 |
| 81 | endothelial cell chemotaxis (GO:0035767) | 3.13386292 |
| 82 | nuclear pore organization (GO:0006999) | 3.12579220 |
| 83 | regulation of RNA export from nucleus (GO:0046831) | 3.12099470 |
| 84 | drug catabolic process (GO:0042737) | 3.11745233 |
| 85 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.08055255 |
| 86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.08055255 |
| 87 | nucleosome disassembly (GO:0006337) | 3.07060590 |
| 88 | protein-DNA complex disassembly (GO:0032986) | 3.07060590 |
| 89 | phospholipid efflux (GO:0033700) | 3.06060280 |
| 90 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.05564797 |
| 91 | atrioventricular valve morphogenesis (GO:0003181) | 3.04601189 |
| 92 | mitotic metaphase plate congression (GO:0007080) | 3.04567349 |
| 93 | translesion synthesis (GO:0019985) | 3.04439786 |
| 94 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.03880761 |
| 95 | regulation of plasminogen activation (GO:0010755) | 3.03691845 |
| 96 | regulation of protein activation cascade (GO:2000257) | 3.03588281 |
| 97 | DNA duplex unwinding (GO:0032508) | 3.02534826 |
| 98 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.02223681 |
| 99 | positive regulation of histone deacetylation (GO:0031065) | 3.02080977 |
| 100 | negative regulation of digestive system process (GO:0060457) | 2.98972806 |
| 101 | DNA geometric change (GO:0032392) | 2.98725694 |
| 102 | negative regulation of mRNA processing (GO:0050686) | 2.98666285 |
| 103 | protein localization to endoplasmic reticulum (GO:0070972) | 2.96774447 |
| 104 | regulation of complement activation (GO:0030449) | 2.95863203 |
| 105 | negative regulation of RNA splicing (GO:0033119) | 2.95211965 |
| 106 | lung-associated mesenchyme development (GO:0060484) | 2.95170519 |
| 107 | negative regulation of mRNA metabolic process (GO:1903312) | 2.94515309 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 2.94415683 |
| 109 | positive regulation of chromosome segregation (GO:0051984) | 2.93768300 |
| 110 | protein-lipid complex subunit organization (GO:0071825) | 2.92691181 |
| 111 | telomere maintenance via recombination (GO:0000722) | 2.92458171 |
| 112 | phosphate ion homeostasis (GO:0055062) | 2.90441737 |
| 113 | trivalent inorganic anion homeostasis (GO:0072506) | 2.90441737 |
| 114 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.90285476 |
| 115 | protein-lipid complex assembly (GO:0065005) | 2.90102298 |
| 116 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.88555033 |
| 117 | positive regulation of glycogen metabolic process (GO:0070875) | 2.88455660 |
| 118 | alkaloid metabolic process (GO:0009820) | 2.88341714 |
| 119 | glutamate metabolic process (GO:0006536) | 2.88033494 |
| 120 | carbohydrate phosphorylation (GO:0046835) | 2.87539148 |
| 121 | positive regulation of chemokine secretion (GO:0090197) | 2.87189513 |
| 122 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.86389510 |
| 123 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.86389510 |
| 124 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.86389510 |
| 125 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.86343778 |
| 126 | iron coordination entity transport (GO:1901678) | 2.86259835 |
| 127 | regulation of synapse maturation (GO:0090128) | 2.85439051 |
| 128 | renal tubule morphogenesis (GO:0061333) | 2.85247641 |
| 129 | bone trabecula formation (GO:0060346) | 2.85042592 |
| 130 | regulation of apoptotic cell clearance (GO:2000425) | 2.84785982 |
| 131 | cell junction maintenance (GO:0034331) | 2.84417397 |
| 132 | epithelial cell fate commitment (GO:0072148) | 2.83477362 |
| 133 | adenosine receptor signaling pathway (GO:0001973) | 2.82923788 |
| 134 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.82859567 |
| 135 | L-phenylalanine catabolic process (GO:0006559) | 2.82080254 |
| 136 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.82080254 |
| 137 | glutathione biosynthetic process (GO:0006750) | 2.81483732 |
| 138 | regulation of triglyceride catabolic process (GO:0010896) | 2.81108802 |
| 139 | protein localization to kinetochore (GO:0034501) | 2.80545519 |
| 140 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.79981807 |
| 141 | sulfate transmembrane transport (GO:1902358) | 2.79529981 |
| 142 | intestinal cholesterol absorption (GO:0030299) | 2.78975214 |
| 143 | rRNA methylation (GO:0031167) | 2.78971535 |
| 144 | mitotic recombination (GO:0006312) | 2.78833985 |
| 145 | acylglycerol homeostasis (GO:0055090) | 2.78791672 |
| 146 | triglyceride homeostasis (GO:0070328) | 2.78791672 |
| 147 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.78296868 |
| 148 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.76400786 |
| 149 | outer ear morphogenesis (GO:0042473) | 2.76135629 |
| 150 | regulation of ARF GTPase activity (GO:0032312) | 2.75938500 |
| 151 | RNA stabilization (GO:0043489) | 2.75849311 |
| 152 | mRNA stabilization (GO:0048255) | 2.75849311 |
| 153 | basement membrane organization (GO:0071711) | 2.75438739 |
| 154 | sulfur amino acid catabolic process (GO:0000098) | 2.75103917 |
| 155 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.75019026 |
| 156 | pore complex assembly (GO:0046931) | 2.74709779 |
| 157 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.74560291 |
| 158 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.74237881 |
| 159 | tetrahydrofolate metabolic process (GO:0046653) | 2.73489475 |
| 160 | DNA topological change (GO:0006265) | 2.73272221 |
| 161 | positive regulation of fatty acid oxidation (GO:0046321) | 2.72762620 |
| 162 | regulation of triglyceride metabolic process (GO:0090207) | 2.72107721 |
| 163 | ncRNA catabolic process (GO:0034661) | 2.71299226 |
| 164 | RNA catabolic process (GO:0006401) | 2.70465131 |
| 165 | positive regulation of hormone metabolic process (GO:0032352) | 2.70267485 |
| 166 | spliceosomal snRNP assembly (GO:0000387) | 2.70064796 |
| 167 | regulation of fatty acid oxidation (GO:0046320) | 2.69925220 |
| 168 | arginine metabolic process (GO:0006525) | 2.68662586 |
| 169 | phosphate ion transmembrane transport (GO:0035435) | 2.68420138 |
| 170 | mitotic nuclear envelope disassembly (GO:0007077) | 2.67150955 |
| 171 | histone H2A acetylation (GO:0043968) | 2.67025927 |
| 172 | negative regulation of cell size (GO:0045792) | 2.66318249 |
| 173 | sex determination (GO:0007530) | 2.66203963 |
| 174 | cholesterol efflux (GO:0033344) | 2.66117164 |
| 175 | urinary tract smooth muscle contraction (GO:0014848) | 2.64539747 |
| 176 | regulation of synapse structural plasticity (GO:0051823) | 2.64479390 |
| 177 | cell proliferation involved in metanephros development (GO:0072203) | 2.63990233 |
| 178 | chromosome condensation (GO:0030261) | 2.63632035 |
| 179 | acute-phase response (GO:0006953) | 2.63376907 |
| 180 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.62539840 |
| 181 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.62264929 |
| 182 | DNA conformation change (GO:0071103) | 2.61485247 |
| 183 | mesenchymal cell proliferation (GO:0010463) | 2.61428981 |
| 184 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.60253395 |
| 185 | mRNA catabolic process (GO:0006402) | 2.60219925 |
| 186 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.60215204 |
| 187 | lipoprotein metabolic process (GO:0042157) | 2.59491739 |
| 188 | base-excision repair (GO:0006284) | 2.59184329 |
| 189 | protein localization to chromosome, centromeric region (GO:0071459) | 2.58682655 |
| 190 | heterochromatin organization (GO:0070828) | 2.58404038 |
| 191 | cellular ketone body metabolic process (GO:0046950) | 2.58304622 |
| 192 | epoxygenase P450 pathway (GO:0019373) | 2.58074426 |
| 193 | 4-hydroxyproline metabolic process (GO:0019471) | 2.57913097 |
| 194 | positive thymic T cell selection (GO:0045059) | 2.56893047 |
| 195 | middle ear morphogenesis (GO:0042474) | 2.55011576 |
| 196 | chromatin assembly or disassembly (GO:0006333) | 2.54479423 |
| 197 | telomere maintenance via telomere lengthening (GO:0010833) | 2.54357992 |
| 198 | chromatin remodeling at centromere (GO:0031055) | 2.52172828 |
| 199 | maternal placenta development (GO:0001893) | 2.51821089 |
| 200 | positive regulation of gastrulation (GO:2000543) | 2.50387427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.28669959 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.85984209 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.57975010 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.48475853 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.47590299 |
| 6 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.36108963 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.15482292 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.96502185 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.90719275 |
| 10 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.87434089 |
| 11 | P68_20966046_ChIP-Seq_HELA_Human | 2.74232423 |
| 12 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.73020736 |
| 13 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.69990049 |
| 14 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.64466762 |
| 15 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.56978544 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.56501072 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.53642828 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.46388900 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.44605125 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.43479343 |
| 21 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.37528617 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.35109219 |
| 23 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.27287031 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.24158471 |
| 25 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.18509566 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.16895387 |
| 27 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.15850820 |
| 28 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.15118782 |
| 29 | SMC4_20622854_ChIP-Seq_HELA_Human | 2.08843638 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.07739933 |
| 31 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.07735725 |
| 32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.05647757 |
| 33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.95905908 |
| 34 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.95431766 |
| 35 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.94831572 |
| 36 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.94016686 |
| 37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90756689 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.86105439 |
| 39 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.83599406 |
| 40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.82305085 |
| 41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.82094185 |
| 42 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80959670 |
| 43 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.80391262 |
| 44 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.78539084 |
| 45 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.78443999 |
| 46 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.76473761 |
| 47 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.75505906 |
| 48 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.74566482 |
| 49 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.73953489 |
| 50 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.71739758 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.70800292 |
| 52 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.70257879 |
| 53 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.69108145 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.68196267 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.67620616 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.66888013 |
| 57 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.65493678 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.63774896 |
| 59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.62834579 |
| 60 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.60917768 |
| 61 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.59985799 |
| 62 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.59249372 |
| 63 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.57806827 |
| 64 | UTX_26944678_Chip-Seq_JUKART_Human | 1.56894074 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.56458025 |
| 66 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.55334792 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54678225 |
| 68 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53727614 |
| 69 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.53278430 |
| 70 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.52106824 |
| 71 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.48216948 |
| 72 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.43634942 |
| 73 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.42058454 |
| 74 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.41898142 |
| 75 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.41862890 |
| 76 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41495238 |
| 77 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.41331038 |
| 78 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40313488 |
| 79 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.40021346 |
| 80 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.38751702 |
| 81 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.38352449 |
| 82 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.36684283 |
| 83 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.36464191 |
| 84 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.36365939 |
| 85 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34882318 |
| 86 | * MAF_26560356_Chip-Seq_TH2_Human | 1.33418162 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33351648 |
| 88 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.31909481 |
| 89 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31351389 |
| 90 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.30765869 |
| 91 | SA1_27219007_Chip-Seq_Bcells_Human | 1.30675422 |
| 92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.29546617 |
| 93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29222549 |
| 94 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.28808632 |
| 95 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.27469880 |
| 96 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.27275798 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26689132 |
| 98 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.26277062 |
| 99 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.25548860 |
| 100 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25014415 |
| 101 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24595914 |
| 102 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24370898 |
| 103 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.24229621 |
| 104 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23181507 |
| 105 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.22559985 |
| 106 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.21789701 |
| 107 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.21253368 |
| 108 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20811551 |
| 109 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.20222486 |
| 110 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19919320 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18762495 |
| 112 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.16895495 |
| 113 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.16639342 |
| 114 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16630213 |
| 115 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.16294362 |
| 116 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.16229479 |
| 117 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16177233 |
| 118 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.16004886 |
| 119 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.15857304 |
| 120 | ERA_21632823_ChIP-Seq_H3396_Human | 1.15486369 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14982237 |
| 122 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.13897500 |
| 123 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13848261 |
| 124 | MYB_26560356_Chip-Seq_TH1_Human | 1.13717872 |
| 125 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13102765 |
| 126 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.12911914 |
| 127 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.12438299 |
| 128 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11283705 |
| 129 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.10354464 |
| 130 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.10021036 |
| 131 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.09821090 |
| 132 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.09563033 |
| 133 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.09352380 |
| 134 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.08491761 |
| 135 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08288280 |
| 136 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07513582 |
| 137 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07415162 |
| 138 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.06669332 |
| 139 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05896068 |
| 140 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.04247760 |
| 141 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03687606 |
| 142 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03572680 |
| 143 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03413137 |
| 144 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02812441 |
| 145 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.01772649 |
| 146 | P300_27268052_Chip-Seq_Bcells_Human | 1.01760094 |
| 147 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01536858 |
| 148 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01368755 |
| 149 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01195746 |
| 150 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01183992 |
| 151 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00815128 |
| 152 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00014072 |
| 153 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98983889 |
| 154 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.98943844 |
| 155 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.98521113 |
| 156 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96865163 |
| 157 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96577841 |
| 158 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.95659432 |
| 159 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.95130362 |
| 160 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.95121808 |
| 161 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95035875 |
| 162 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.94997485 |
| 163 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.94010074 |
| 164 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.93399633 |
| 165 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93051883 |
| 166 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.92820155 |
| 167 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92579114 |
| 168 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92014988 |
| 169 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91953925 |
| 170 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91063531 |
| 171 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90721158 |
| 172 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88625128 |
| 173 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.88358876 |
| 174 | MYB_26560356_Chip-Seq_TH2_Human | 0.87921781 |
| 175 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.87572743 |
| 176 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.87320067 |
| 177 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.86508420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000013_abnormal_adipose_tissue | 4.41161479 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.21694179 |
| 3 | MP0005360_urolithiasis | 3.92516807 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.43103368 |
| 5 | MP0010030_abnormal_orbit_morphology | 3.38739791 |
| 6 | MP0005365_abnormal_bile_salt | 3.31605371 |
| 7 | MP0005409_darkened_coat_color | 3.24658385 |
| 8 | MP0001986_abnormal_taste_sensitivity | 3.23230108 |
| 9 | MP0003111_abnormal_nucleus_morphology | 2.94306807 |
| 10 | MP0000003_abnormal_adipose_tissue | 2.89475691 |
| 11 | MP0001293_anophthalmia | 2.75360841 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.74679892 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.59782766 |
| 14 | MP0002163_abnormal_gland_morphology | 2.56637169 |
| 15 | MP0003136_yellow_coat_color | 2.54810128 |
| 16 | MP0000566_synostosis | 2.54447305 |
| 17 | MP0002396_abnormal_hematopoietic_system | 2.47282930 |
| 18 | MP0010094_abnormal_chromosome_stability | 2.45970504 |
| 19 | MP0000537_abnormal_urethra_morphology | 2.38320007 |
| 20 | MP0005171_absent_coat_pigmentation | 2.36443695 |
| 21 | MP0008875_abnormal_xenobiotic_pharmacok | 2.33723030 |
| 22 | MP0003879_abnormal_hair_cell | 2.28792521 |
| 23 | MP0003077_abnormal_cell_cycle | 2.27473555 |
| 24 | MP0005332_abnormal_amino_acid | 2.14786128 |
| 25 | MP0000538_abnormal_urinary_bladder | 2.08984777 |
| 26 | MP0003195_calcinosis | 2.08357192 |
| 27 | MP0004043_abnormal_pH_regulation | 2.07340383 |
| 28 | MP0003183_abnormal_peptide_metabolism | 2.07161687 |
| 29 | MP0010329_abnormal_lipoprotein_level | 1.99682664 |
| 30 | MP0001756_abnormal_urination | 1.98271007 |
| 31 | MP0002653_abnormal_ependyma_morphology | 1.95923145 |
| 32 | MP0002102_abnormal_ear_morphology | 1.89949522 |
| 33 | MP0008932_abnormal_embryonic_tissue | 1.88694503 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.85729772 |
| 35 | MP0001188_hyperpigmentation | 1.85534785 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.84881464 |
| 37 | MP0001502_abnormal_circadian_rhythm | 1.84015095 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.82885190 |
| 39 | MP0000049_abnormal_middle_ear | 1.78961147 |
| 40 | MP0005085_abnormal_gallbladder_physiolo | 1.72019427 |
| 41 | MP0009053_abnormal_anal_canal | 1.66981380 |
| 42 | MP0000678_abnormal_parathyroid_gland | 1.65492130 |
| 43 | MP0003123_paternal_imprinting | 1.61703327 |
| 44 | MP0000613_abnormal_salivary_gland | 1.59023259 |
| 45 | MP0005174_abnormal_tail_pigmentation | 1.56447456 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.51974445 |
| 47 | MP0002876_abnormal_thyroid_physiology | 1.51263663 |
| 48 | MP0008057_abnormal_DNA_replication | 1.51046295 |
| 49 | MP0008007_abnormal_cellular_replicative | 1.50038864 |
| 50 | MP0010307_abnormal_tumor_latency | 1.49661337 |
| 51 | MP0002092_abnormal_eye_morphology | 1.49171884 |
| 52 | MP0001849_ear_inflammation | 1.48816180 |
| 53 | MP0002282_abnormal_trachea_morphology | 1.48691976 |
| 54 | MP0004019_abnormal_vitamin_homeostasis | 1.48552963 |
| 55 | MP0001765_abnormal_ion_homeostasis | 1.46804991 |
| 56 | MP0005645_abnormal_hypothalamus_physiol | 1.46447517 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.45820791 |
| 58 | MP0001666_abnormal_nutrient_absorption | 1.45410552 |
| 59 | MP0000490_abnormal_crypts_of | 1.40060207 |
| 60 | MP0002249_abnormal_larynx_morphology | 1.39665458 |
| 61 | MP0001661_extended_life_span | 1.39524977 |
| 62 | MP0000350_abnormal_cell_proliferation | 1.37796515 |
| 63 | MP0000428_abnormal_craniofacial_morphol | 1.37054060 |
| 64 | MP0002638_abnormal_pupillary_reflex | 1.36865521 |
| 65 | MP0008058_abnormal_DNA_repair | 1.36144462 |
| 66 | MP0000383_abnormal_hair_follicle | 1.33017453 |
| 67 | MP0004858_abnormal_nervous_system | 1.31614891 |
| 68 | MP0003942_abnormal_urinary_system | 1.29941704 |
| 69 | MP0001348_abnormal_lacrimal_gland | 1.28372842 |
| 70 | MP0003566_abnormal_cell_adhesion | 1.27100018 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.27012644 |
| 72 | MP0005375_adipose_tissue_phenotype | 1.26996939 |
| 73 | MP0009379_abnormal_foot_pigmentation | 1.26526160 |
| 74 | MP0003763_abnormal_thymus_physiology | 1.25898099 |
| 75 | MP0001873_stomach_inflammation | 1.25737135 |
| 76 | MP0001664_abnormal_digestion | 1.24683770 |
| 77 | MP0003315_abnormal_perineum_morphology | 1.24505055 |
| 78 | MP0001968_abnormal_touch/_nociception | 1.24285889 |
| 79 | MP0003115_abnormal_respiratory_system | 1.23631311 |
| 80 | MP0009780_abnormal_chondrocyte_physiolo | 1.21001797 |
| 81 | MP0001697_abnormal_embryo_size | 1.19881202 |
| 82 | MP0002697_abnormal_eye_size | 1.18221029 |
| 83 | MP0003283_abnormal_digestive_organ | 1.17542842 |
| 84 | MP0000733_abnormal_muscle_development | 1.16959010 |
| 85 | MP0004381_abnormal_hair_follicle | 1.16574450 |
| 86 | MP0009672_abnormal_birth_weight | 1.16085501 |
| 87 | MP0005448_abnormal_energy_balance | 1.15677318 |
| 88 | MP0003937_abnormal_limbs/digits/tail_de | 1.15544503 |
| 89 | MP0002118_abnormal_lipid_homeostasis | 1.15281446 |
| 90 | MP0005330_cardiomyopathy | 1.14466320 |
| 91 | MP0009643_abnormal_urine_homeostasis | 1.14050094 |
| 92 | MP0000751_myopathy | 1.13500005 |
| 93 | MP0003300_gastrointestinal_ulcer | 1.13154553 |
| 94 | MP0002166_altered_tumor_susceptibility | 1.12767544 |
| 95 | MP0009384_cardiac_valve_regurgitation | 1.11039488 |
| 96 | MP0000569_abnormal_digit_pigmentation | 1.10193408 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 1.09700259 |
| 98 | MP0002080_prenatal_lethality | 1.09664020 |
| 99 | MP0001915_intracranial_hemorrhage | 1.08028882 |
| 100 | MP0005380_embryogenesis_phenotype | 1.07790707 |
| 101 | MP0001672_abnormal_embryogenesis/_devel | 1.07790707 |
| 102 | MP0003119_abnormal_digestive_system | 1.07383676 |
| 103 | MP0002398_abnormal_bone_marrow | 1.06822403 |
| 104 | MP0004264_abnormal_extraembryonic_tissu | 1.05124723 |
| 105 | MP0004185_abnormal_adipocyte_glucose | 1.04999801 |
| 106 | MP0003385_abnormal_body_wall | 1.04559943 |
| 107 | MP0005083_abnormal_biliary_tract | 1.04537711 |
| 108 | MP0001730_embryonic_growth_arrest | 1.01856739 |
| 109 | MP0002085_abnormal_embryonic_tissue | 1.01016634 |
| 110 | MP0002132_abnormal_respiratory_system | 0.98676557 |
| 111 | MP0002932_abnormal_joint_morphology | 0.97626697 |
| 112 | MP0004197_abnormal_fetal_growth/weight/ | 0.97370510 |
| 113 | MP0001944_abnormal_pancreas_morphology | 0.96980782 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.96936634 |
| 115 | MP0005220_abnormal_exocrine_pancreas | 0.95533984 |
| 116 | MP0001346_abnormal_lacrimal_gland | 0.94903436 |
| 117 | MP0000313_abnormal_cell_death | 0.94245599 |
| 118 | MP0003121_genomic_imprinting | 0.93447419 |
| 119 | MP0003935_abnormal_craniofacial_develop | 0.92728167 |
| 120 | MP0003045_fibrosis | 0.92694610 |
| 121 | MP0002088_abnormal_embryonic_growth/wei | 0.92678955 |
| 122 | MP0003984_embryonic_growth_retardation | 0.92569471 |
| 123 | MP0000689_abnormal_spleen_morphology | 0.91150952 |
| 124 | MP0003011_delayed_dark_adaptation | 0.90006227 |
| 125 | MP0002111_abnormal_tail_morphology | 0.89467794 |
| 126 | MP0002138_abnormal_hepatobiliary_system | 0.88251963 |
| 127 | MP0002086_abnormal_extraembryonic_tissu | 0.87446288 |
| 128 | MP0003122_maternal_imprinting | 0.87087581 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.87081340 |
| 130 | MP0009840_abnormal_foam_cell | 0.86787123 |
| 131 | MP0002722_abnormal_immune_system | 0.85374832 |
| 132 | MP0002234_abnormal_pharynx_morphology | 0.84118443 |
| 133 | MP0005197_abnormal_uvea_morphology | 0.83025846 |
| 134 | MP0002084_abnormal_developmental_patter | 0.82937768 |
| 135 | MP0010386_abnormal_urinary_bladder | 0.82806170 |
| 136 | MP0001286_abnormal_eye_development | 0.82745541 |
| 137 | MP0000462_abnormal_digestive_system | 0.81646026 |
| 138 | MP0000609_abnormal_liver_physiology | 0.81375191 |
| 139 | MP0002938_white_spotting | 0.80181371 |
| 140 | MP0002822_catalepsy | 0.79052205 |
| 141 | MP0008961_abnormal_basal_metabolism | 0.78512759 |
| 142 | MP0003646_muscle_fatigue | 0.77938720 |
| 143 | MP0001270_distended_abdomen | 0.77593709 |
| 144 | MP0005451_abnormal_body_composition | 0.77477424 |
| 145 | MP0005167_abnormal_blood-brain_barrier | 0.77121474 |
| 146 | MP0000015_abnormal_ear_pigmentation | 0.76240707 |
| 147 | MP0002429_abnormal_blood_cell | 0.75297512 |
| 148 | MP0002933_joint_inflammation | 0.75087638 |
| 149 | MP0002735_abnormal_chemical_nociception | 0.74739238 |
| 150 | MP0002136_abnormal_kidney_physiology | 0.74682908 |
| 151 | MP0005636_abnormal_mineral_homeostasis | 0.74059846 |
| 152 | MP0005381_digestive/alimentary_phenotyp | 0.73940891 |
| 153 | MP0001958_emphysema | 0.73706515 |
| 154 | MP0005187_abnormal_penis_morphology | 0.73104991 |
| 155 | MP0001800_abnormal_humoral_immune | 0.72903812 |
| 156 | MP0003453_abnormal_keratinocyte_physiol | 0.71216654 |
| 157 | MP0003755_abnormal_palate_morphology | 0.71062942 |
| 158 | MP0002019_abnormal_tumor_incidence | 0.70229381 |
| 159 | MP0001764_abnormal_homeostasis | 0.70129140 |
| 160 | MP0000716_abnormal_immune_system | 0.69498786 |
| 161 | MP0002160_abnormal_reproductive_system | 0.69445652 |
| 162 | MP0005377_hearing/vestibular/ear_phenot | 0.69358142 |
| 163 | MP0003878_abnormal_ear_physiology | 0.69358142 |
| 164 | MP0003705_abnormal_hypodermis_morpholog | 0.68367525 |
| 165 | MP0005391_vision/eye_phenotype | 0.68086661 |
| 166 | MP0002970_abnormal_white_adipose | 0.67445956 |
| 167 | MP0000470_abnormal_stomach_morphology | 0.66788794 |
| 168 | MP0003953_abnormal_hormone_level | 0.65733576 |
| 169 | MP0004133_heterotaxia | 0.62875700 |
| 170 | MP0003252_abnormal_bile_duct | 0.62295651 |
| 171 | MP0000639_abnormal_adrenal_gland | 0.59810306 |
| 172 | MP0009642_abnormal_blood_homeostasis | 0.59639827 |
| 173 | MP0009931_abnormal_skin_appearance | 0.59095706 |
| 174 | MP0004145_abnormal_muscle_electrophysio | 0.57659078 |
| 175 | MP0003137_abnormal_impulse_conducting | 0.57367224 |
| 176 | MP0004130_abnormal_muscle_cell | 0.56979686 |
| 177 | MP0008775_abnormal_heart_ventricle | 0.55632886 |
| 178 | MP0003329_amyloid_beta_deposits | 0.54754908 |
| 179 | MP0003279_aneurysm | 0.52657712 |
| 180 | MP0003866_abnormal_defecation | 0.52025885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal gallbladder physiology (HP:0012438) | 6.77463542 |
| 2 | Cholecystitis (HP:0001082) | 6.77463542 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 4.72588871 |
| 4 | Peripheral hypomyelination (HP:0007182) | 4.68586352 |
| 5 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 4.48812387 |
| 6 | Morphological abnormality of the middle ear (HP:0008609) | 4.47399596 |
| 7 | Thin bony cortex (HP:0002753) | 4.41921822 |
| 8 | Joint hemorrhage (HP:0005261) | 4.33755414 |
| 9 | Testicular atrophy (HP:0000029) | 4.30150623 |
| 10 | Absent eyelashes (HP:0000561) | 4.11047974 |
| 11 | Deep venous thrombosis (HP:0002625) | 4.06518486 |
| 12 | Bilateral microphthalmos (HP:0007633) | 4.02359971 |
| 13 | Chin dimple (HP:0010751) | 3.89865508 |
| 14 | Rib fusion (HP:0000902) | 3.85722234 |
| 15 | Malnutrition (HP:0004395) | 3.78948529 |
| 16 | Hemorrhage of the eye (HP:0011885) | 3.71392707 |
| 17 | Bifid tongue (HP:0010297) | 3.63245871 |
| 18 | Ulnar bowing (HP:0003031) | 3.58397506 |
| 19 | Intestinal fistula (HP:0100819) | 3.48440155 |
| 20 | Midline defect of the nose (HP:0004122) | 3.45308143 |
| 21 | Down-sloping shoulders (HP:0200021) | 3.45117525 |
| 22 | Reticulocytopenia (HP:0001896) | 3.41069608 |
| 23 | Vaginal fistula (HP:0004320) | 3.39401604 |
| 24 | Thoracolumbar scoliosis (HP:0002944) | 3.31055808 |
| 25 | Annular pancreas (HP:0001734) | 3.27163242 |
| 26 | Turricephaly (HP:0000262) | 3.26552786 |
| 27 | Facial cleft (HP:0002006) | 3.24429261 |
| 28 | Broad face (HP:0000283) | 3.21009512 |
| 29 | Abnormality of reticulocytes (HP:0004312) | 3.12975271 |
| 30 | Cholelithiasis (HP:0001081) | 3.11206747 |
| 31 | Severe visual impairment (HP:0001141) | 3.01665275 |
| 32 | Rectovaginal fistula (HP:0000143) | 3.00434985 |
| 33 | Rectal fistula (HP:0100590) | 3.00434985 |
| 34 | Overlapping toe (HP:0001845) | 3.00266078 |
| 35 | Reticulocytosis (HP:0001923) | 2.97172207 |
| 36 | Cerebral aneurysm (HP:0004944) | 2.93554786 |
| 37 | Abnormality of the fingertips (HP:0001211) | 2.87344038 |
| 38 | Rectal prolapse (HP:0002035) | 2.85244116 |
| 39 | Cutaneous finger syndactyly (HP:0010554) | 2.84682098 |
| 40 | Coronal craniosynostosis (HP:0004440) | 2.84197472 |
| 41 | Abnormal number of incisors (HP:0011064) | 2.81997537 |
| 42 | Absent eyebrow (HP:0002223) | 2.81155801 |
| 43 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.80106222 |
| 44 | Facial hemangioma (HP:0000329) | 2.79635043 |
| 45 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.77817650 |
| 46 | Xanthomatosis (HP:0000991) | 2.76353334 |
| 47 | Hyperacusis (HP:0010780) | 2.76023609 |
| 48 | J-shaped sella turcica (HP:0002680) | 2.74963069 |
| 49 | Abnormality of the lacrimal duct (HP:0011481) | 2.72402723 |
| 50 | Joint stiffness (HP:0001387) | 2.68330233 |
| 51 | Hypobetalipoproteinemia (HP:0003563) | 2.67660922 |
| 52 | Abnormal lung lobation (HP:0002101) | 2.66417752 |
| 53 | Neoplasm of the heart (HP:0100544) | 2.66395747 |
| 54 | Abnormal gallbladder morphology (HP:0012437) | 2.64522049 |
| 55 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.60329541 |
| 56 | Bicornuate uterus (HP:0000813) | 2.59140105 |
| 57 | Cutaneous syndactyly (HP:0012725) | 2.58414837 |
| 58 | Choanal stenosis (HP:0000452) | 2.57062087 |
| 59 | Cervical subluxation (HP:0003308) | 2.55223918 |
| 60 | Renal duplication (HP:0000075) | 2.53057538 |
| 61 | Obstructive sleep apnea (HP:0002870) | 2.50157034 |
| 62 | Confusion (HP:0001289) | 2.49992332 |
| 63 | Complement deficiency (HP:0004431) | 2.49292059 |
| 64 | Abnormality of the intrinsic pathway (HP:0010989) | 2.48714373 |
| 65 | Anophthalmia (HP:0000528) | 2.46926751 |
| 66 | Popliteal pterygium (HP:0009756) | 2.46497845 |
| 67 | Skull defect (HP:0001362) | 2.45687737 |
| 68 | Myelomeningocele (HP:0002475) | 2.45003817 |
| 69 | Diastasis recti (HP:0001540) | 2.44551299 |
| 70 | Cleft eyelid (HP:0000625) | 2.43013114 |
| 71 | Vertebral arch anomaly (HP:0008438) | 2.41459900 |
| 72 | Asymmetry of the thorax (HP:0001555) | 2.39924060 |
| 73 | Akinesia (HP:0002304) | 2.39306047 |
| 74 | Abnormality of the nasolacrimal system (HP:0000614) | 2.39289536 |
| 75 | Stridor (HP:0010307) | 2.38666292 |
| 76 | Overriding aorta (HP:0002623) | 2.38585522 |
| 77 | Lymphangioma (HP:0100764) | 2.37273185 |
| 78 | Atresia of the external auditory canal (HP:0000413) | 2.34165109 |
| 79 | Flat acetabular roof (HP:0003180) | 2.32333353 |
| 80 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.31401806 |
| 81 | Recurrent bronchitis (HP:0002837) | 2.29092921 |
| 82 | Poikiloderma (HP:0001029) | 2.28763157 |
| 83 | Abnormality of the pubic bones (HP:0003172) | 2.28380250 |
| 84 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.28355749 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28036422 |
| 86 | Mucopolysacchariduria (HP:0008155) | 2.28036422 |
| 87 | Mesangial abnormality (HP:0001966) | 2.25855346 |
| 88 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.25392694 |
| 89 | Elfin facies (HP:0004428) | 2.25256969 |
| 90 | Bowed forearm bones (HP:0003956) | 2.22843373 |
| 91 | Bowing of the arm (HP:0006488) | 2.22843373 |
| 92 | Hyperlipoproteinemia (HP:0010980) | 2.22393820 |
| 93 | Renovascular hypertension (HP:0100817) | 2.21790548 |
| 94 | Neonatal onset (HP:0003623) | 2.21304388 |
| 95 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.20182161 |
| 96 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16826767 |
| 97 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16826767 |
| 98 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16826767 |
| 99 | Pterygium (HP:0001059) | 2.16520115 |
| 100 | Decreased circulating renin level (HP:0003351) | 2.16062146 |
| 101 | Bronchomalacia (HP:0002780) | 2.15863411 |
| 102 | Delayed epiphyseal ossification (HP:0002663) | 2.14116345 |
| 103 | Patellar aplasia (HP:0006443) | 2.13380609 |
| 104 | Hydroxyprolinuria (HP:0003080) | 2.12745428 |
| 105 | Abnormality of proline metabolism (HP:0010907) | 2.12745428 |
| 106 | Abnormality of homocysteine metabolism (HP:0010919) | 2.12693566 |
| 107 | Homocystinuria (HP:0002156) | 2.12693566 |
| 108 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.12099354 |
| 109 | Renal hypoplasia (HP:0000089) | 2.11830076 |
| 110 | Submucous cleft hard palate (HP:0000176) | 2.08645785 |
| 111 | Systemic lupus erythematosus (HP:0002725) | 2.08197531 |
| 112 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.05407259 |
| 113 | Panhypogammaglobulinemia (HP:0003139) | 2.03933732 |
| 114 | Abnormality of the 1st metacarpal (HP:0010009) | 2.03929138 |
| 115 | Delayed CNS myelination (HP:0002188) | 2.03487142 |
| 116 | Late onset (HP:0003584) | 2.02799466 |
| 117 | Abnormality of the renal collecting system (HP:0004742) | 2.02764235 |
| 118 | Squamous cell carcinoma (HP:0002860) | 2.02478798 |
| 119 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.00185044 |
| 120 | Short 4th metacarpal (HP:0010044) | 2.00185044 |
| 121 | Abnormality of complement system (HP:0005339) | 1.99739747 |
| 122 | Meckel diverticulum (HP:0002245) | 1.98647913 |
| 123 | Hyperbilirubinemia (HP:0002904) | 1.98389617 |
| 124 | Chromsome breakage (HP:0040012) | 1.98230187 |
| 125 | Enlarged epiphyses (HP:0010580) | 1.97822378 |
| 126 | Tracheal stenosis (HP:0002777) | 1.97808852 |
| 127 | Anteriorly placed anus (HP:0001545) | 1.96397935 |
| 128 | Split foot (HP:0001839) | 1.93871333 |
| 129 | Bicuspid aortic valve (HP:0001647) | 1.93456335 |
| 130 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.93005921 |
| 131 | Abdominal distention (HP:0003270) | 1.92858613 |
| 132 | Flat capital femoral epiphysis (HP:0003370) | 1.91648463 |
| 133 | Hypolipoproteinemia (HP:0010981) | 1.89862777 |
| 134 | Abnormality of the thymus (HP:0000777) | 1.89836552 |
| 135 | Broad distal phalanx of finger (HP:0009836) | 1.89273064 |
| 136 | Decreased muscle mass (HP:0003199) | 1.89117021 |
| 137 | Abnormality of the gallbladder (HP:0005264) | 1.88933366 |
| 138 | Short phalanx of the thumb (HP:0009660) | 1.88508926 |
| 139 | Short chin (HP:0000331) | 1.87921887 |
| 140 | Hypoalbuminemia (HP:0003073) | 1.87545912 |
| 141 | Abnormal albumin level (HP:0012116) | 1.87545912 |
| 142 | Myopathic facies (HP:0002058) | 1.86462878 |
| 143 | Glomerulonephritis (HP:0000099) | 1.86282447 |
| 144 | Flattened epiphyses (HP:0003071) | 1.86073999 |
| 145 | Ketosis (HP:0001946) | 1.85996769 |
| 146 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.84960019 |
| 147 | Increased nuchal translucency (HP:0010880) | 1.84760388 |
| 148 | Hypoalphalipoproteinemia (HP:0003233) | 1.83715416 |
| 149 | Abnormality of the ileum (HP:0001549) | 1.83080483 |
| 150 | Acute lymphatic leukemia (HP:0006721) | 1.80689822 |
| 151 | Abnormality of the vitreous humor (HP:0004327) | 1.80254235 |
| 152 | Widely patent fontanelles and sutures (HP:0004492) | 1.80007715 |
| 153 | Megaloblastic anemia (HP:0001889) | 1.79782576 |
| 154 | Oligodactyly (HP:0012165) | 1.79591280 |
| 155 | Insomnia (HP:0100785) | 1.79199943 |
| 156 | Cellular immunodeficiency (HP:0005374) | 1.78877193 |
| 157 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.78828893 |
| 158 | Acanthocytosis (HP:0001927) | 1.78761441 |
| 159 | Visceral angiomatosis (HP:0100761) | 1.78741200 |
| 160 | Skin tags (HP:0010609) | 1.78383173 |
| 161 | Abnormality of the carotid arteries (HP:0005344) | 1.78351474 |
| 162 | Wide nose (HP:0000445) | 1.76586289 |
| 163 | Oligodactyly (hands) (HP:0001180) | 1.76108812 |
| 164 | Hypophosphatemic rickets (HP:0004912) | 1.75391630 |
| 165 | Basal cell carcinoma (HP:0002671) | 1.74562943 |
| 166 | Preauricular skin tag (HP:0000384) | 1.73807635 |
| 167 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.73755366 |
| 168 | Villous atrophy (HP:0011473) | 1.73755366 |
| 169 | Congenital stationary night blindness (HP:0007642) | 1.73101971 |
| 170 | Abnormality of the femoral head (HP:0003368) | 1.72458605 |
| 171 | Dicarboxylic aciduria (HP:0003215) | 1.72324497 |
| 172 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.72324497 |
| 173 | Protuberant abdomen (HP:0001538) | 1.71898728 |
| 174 | Pallor (HP:0000980) | 1.71672326 |
| 175 | Aplasia of the musculature (HP:0100854) | 1.71501746 |
| 176 | Shallow orbits (HP:0000586) | 1.71182167 |
| 177 | Absent phalangeal crease (HP:0006109) | 1.70529238 |
| 178 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.70306747 |
| 179 | Short 1st metacarpal (HP:0010034) | 1.70306747 |
| 180 | Short 5th finger (HP:0009237) | 1.70289834 |
| 181 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.70110315 |
| 182 | Narrow nasal bridge (HP:0000446) | 1.69701083 |
| 183 | Stomach cancer (HP:0012126) | 1.69441948 |
| 184 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.69111053 |
| 185 | Short humerus (HP:0005792) | 1.69081295 |
| 186 | Pendular nystagmus (HP:0012043) | 1.68994785 |
| 187 | Muscle fiber atrophy (HP:0100295) | 1.68824345 |
| 188 | Urethral obstruction (HP:0000796) | 1.68172132 |
| 189 | Cheilitis (HP:0100825) | 1.67954097 |
| 190 | Macrocytic anemia (HP:0001972) | 1.67295785 |
| 191 | Hypospadias (HP:0000047) | 1.66271363 |
| 192 | Abnormality of the aortic arch (HP:0012303) | 1.66174291 |
| 193 | Thin ribs (HP:0000883) | 1.64921732 |
| 194 | Abnormality of the preputium (HP:0100587) | 1.64559012 |
| 195 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.63456905 |
| 196 | Ureteral stenosis (HP:0000071) | 1.63002783 |
| 197 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.61868600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 9.36091551 |
| 2 | MAPK15 | 3.76033509 |
| 3 | WNK4 | 3.69458602 |
| 4 | BLK | 3.39688952 |
| 5 | TESK2 | 2.98019386 |
| 6 | MAP4K1 | 2.67104626 |
| 7 | MAP2K6 | 2.52760441 |
| 8 | PKN2 | 2.38927755 |
| 9 | TRIB3 | 2.35174092 |
| 10 | MAP3K10 | 2.33661842 |
| 11 | FLT3 | 2.17395257 |
| 12 | NEK2 | 2.07695225 |
| 13 | MST1R | 1.89014661 |
| 14 | TNK2 | 1.88000932 |
| 15 | MAP3K7 | 1.76685144 |
| 16 | CDC7 | 1.68428909 |
| 17 | MKNK2 | 1.61085677 |
| 18 | PHKG1 | 1.58371322 |
| 19 | PHKG2 | 1.58371322 |
| 20 | CDK12 | 1.54501604 |
| 21 | PRKD2 | 1.53372335 |
| 22 | ZAP70 | 1.53069631 |
| 23 | MARK2 | 1.52712742 |
| 24 | TESK1 | 1.52163414 |
| 25 | CDK8 | 1.51622314 |
| 26 | EEF2K | 1.50185811 |
| 27 | WNK1 | 1.50105199 |
| 28 | SIK1 | 1.50069833 |
| 29 | PTK2B | 1.49914795 |
| 30 | SMG1 | 1.45518611 |
| 31 | ZAK | 1.44351210 |
| 32 | NTRK3 | 1.40973854 |
| 33 | RPS6KA2 | 1.38588111 |
| 34 | PTK6 | 1.34674988 |
| 35 | NME2 | 1.28612037 |
| 36 | CAMK1D | 1.27653666 |
| 37 | CDC42BPA | 1.26070441 |
| 38 | SIK2 | 1.21514338 |
| 39 | FGFR3 | 1.19980118 |
| 40 | DAPK2 | 1.19042234 |
| 41 | CDK7 | 1.17819306 |
| 42 | KIT | 1.15823482 |
| 43 | RPS6KL1 | 1.13708615 |
| 44 | RPS6KC1 | 1.13708615 |
| 45 | TTN | 1.07062086 |
| 46 | TYRO3 | 1.06447317 |
| 47 | RPS6KA6 | 1.05624071 |
| 48 | ERN1 | 1.05523175 |
| 49 | RPS6KA4 | 1.04382366 |
| 50 | SRPK1 | 1.02843203 |
| 51 | PDPK1 | 1.00203472 |
| 52 | ATR | 0.98808386 |
| 53 | WEE1 | 0.98241759 |
| 54 | PRKD3 | 0.98110264 |
| 55 | MUSK | 0.97697359 |
| 56 | MET | 0.94535401 |
| 57 | LMTK2 | 0.94364048 |
| 58 | EPHB2 | 0.94137057 |
| 59 | MAPK12 | 0.90615765 |
| 60 | MKNK1 | 0.89774204 |
| 61 | BTK | 0.87342461 |
| 62 | NEK9 | 0.86742385 |
| 63 | MAPKAPK3 | 0.86540849 |
| 64 | PRKAA1 | 0.85084760 |
| 65 | AURKB | 0.85022515 |
| 66 | CAMK1G | 0.83946576 |
| 67 | MAP3K6 | 0.83610087 |
| 68 | INSRR | 0.83200357 |
| 69 | PTK2 | 0.81702699 |
| 70 | CSF1R | 0.81565759 |
| 71 | STK16 | 0.81391480 |
| 72 | PRKCI | 0.80802707 |
| 73 | PASK | 0.79665905 |
| 74 | RPS6KB2 | 0.79558893 |
| 75 | ILK | 0.78249886 |
| 76 | MAP3K8 | 0.78140160 |
| 77 | VRK1 | 0.77127694 |
| 78 | PLK1 | 0.76379550 |
| 79 | CDK4 | 0.76021166 |
| 80 | HIPK2 | 0.75191875 |
| 81 | STK39 | 0.74045748 |
| 82 | TYK2 | 0.73279284 |
| 83 | MYLK | 0.72545077 |
| 84 | PAK4 | 0.72544005 |
| 85 | MAPK11 | 0.72436630 |
| 86 | DDR2 | 0.71530840 |
| 87 | TAOK3 | 0.68886939 |
| 88 | MTOR | 0.68784367 |
| 89 | CHEK2 | 0.67603682 |
| 90 | STK4 | 0.66127983 |
| 91 | RET | 0.65670507 |
| 92 | MAPK7 | 0.65631463 |
| 93 | RIPK1 | 0.64262612 |
| 94 | TEC | 0.63972493 |
| 95 | MAP2K3 | 0.62488482 |
| 96 | BRD4 | 0.62421214 |
| 97 | TBK1 | 0.59887751 |
| 98 | ACVR1B | 0.59148931 |
| 99 | FGFR4 | 0.57883600 |
| 100 | MAPK8 | 0.57670708 |
| 101 | FGFR2 | 0.57224444 |
| 102 | TGFBR1 | 0.56886752 |
| 103 | SGK494 | 0.56271776 |
| 104 | SGK223 | 0.56271776 |
| 105 | DAPK3 | 0.55829253 |
| 106 | CAMK4 | 0.55357949 |
| 107 | BUB1 | 0.55259926 |
| 108 | TSSK6 | 0.54959812 |
| 109 | CAMKK2 | 0.53875894 |
| 110 | NME1 | 0.53644589 |
| 111 | MAP2K4 | 0.53494287 |
| 112 | AKT2 | 0.53307210 |
| 113 | CDK2 | 0.51721209 |
| 114 | JAK3 | 0.50076544 |
| 115 | CAMK1 | 0.49988580 |
| 116 | ATM | 0.49370252 |
| 117 | EPHA2 | 0.47832648 |
| 118 | LIMK1 | 0.47680506 |
| 119 | PDGFRA | 0.47424308 |
| 120 | MAP2K2 | 0.47366630 |
| 121 | ICK | 0.46813754 |
| 122 | TXK | 0.46353185 |
| 123 | CHEK1 | 0.43764387 |
| 124 | GRK6 | 0.43343650 |
| 125 | TTK | 0.43196486 |
| 126 | LRRK2 | 0.42595631 |
| 127 | PRKCH | 0.42212370 |
| 128 | CHUK | 0.41656200 |
| 129 | FRK | 0.41448395 |
| 130 | STK11 | 0.41263851 |
| 131 | SYK | 0.41119053 |
| 132 | SCYL2 | 0.40033032 |
| 133 | IRAK3 | 0.39911892 |
| 134 | AKT3 | 0.39445753 |
| 135 | BMX | 0.39134433 |
| 136 | PRKG2 | 0.39007927 |
| 137 | LCK | 0.38925021 |
| 138 | MARK3 | 0.38339781 |
| 139 | IRAK2 | 0.38246778 |
| 140 | JAK2 | 0.37905844 |
| 141 | RPS6KA1 | 0.37844668 |
| 142 | TAOK1 | 0.36817115 |
| 143 | PDK1 | 0.36435926 |
| 144 | NLK | 0.35468735 |
| 145 | ITK | 0.35170164 |
| 146 | PIM1 | 0.35046224 |
| 147 | DYRK1B | 0.33697772 |
| 148 | STK10 | 0.31888507 |
| 149 | PRKD1 | 0.31333117 |
| 150 | CAMKK1 | 0.31330383 |
| 151 | ERBB2 | 0.30969226 |
| 152 | AKT1 | 0.30960986 |
| 153 | AURKA | 0.29265214 |
| 154 | MAPK1 | 0.29251967 |
| 155 | PRKAA2 | 0.29173896 |
| 156 | PIK3CA | 0.28575191 |
| 157 | PRKDC | 0.28434442 |
| 158 | PAK2 | 0.28313777 |
| 159 | PRKCZ | 0.28184155 |
| 160 | SGK1 | 0.27248062 |
| 161 | CDK1 | 0.26681965 |
| 162 | NTRK2 | 0.25246122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 9.86016878 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.27549090 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.20112057 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.19118321 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95634794 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.75053088 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.72929153 |
| 8 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.69385770 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.40028467 |
| 10 | Galactose metabolism_Homo sapiens_hsa00052 | 2.37383876 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.34609442 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.34040760 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 2.23958647 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 2.15145322 |
| 15 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.11097381 |
| 16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.98508070 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.91102316 |
| 18 | ABC transporters_Homo sapiens_hsa02010 | 1.87317329 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.84210919 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59986750 |
| 21 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.56788179 |
| 22 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.50917798 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47744403 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.46970506 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.45708357 |
| 26 | Cell cycle_Homo sapiens_hsa04110 | 1.44410965 |
| 27 | Lysine degradation_Homo sapiens_hsa00310 | 1.39332270 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37778237 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.36917524 |
| 30 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.36624247 |
| 31 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.34445497 |
| 32 | RNA transport_Homo sapiens_hsa03013 | 1.34165999 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.33218731 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.32369516 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.30027037 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.25010492 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23708893 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.23288399 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17548958 |
| 40 | Insulin secretion_Homo sapiens_hsa04911 | 1.15490666 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11196098 |
| 42 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.05894121 |
| 43 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.04512622 |
| 44 | Mineral absorption_Homo sapiens_hsa04978 | 1.03289814 |
| 45 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.03195120 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01566265 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00920990 |
| 48 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.00650956 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98737134 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97330367 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.97077642 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96226009 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.96003515 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95026675 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93544870 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93087106 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93081114 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92144586 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91402092 |
| 60 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.90305464 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.90288583 |
| 62 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.90220357 |
| 63 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89613726 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88791627 |
| 65 | Cocaine addiction_Homo sapiens_hsa05030 | 0.84929658 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.79192681 |
| 67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78716921 |
| 68 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78716029 |
| 69 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.77530085 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76154907 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75892047 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.75456469 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75437752 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75115288 |
| 75 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.74452965 |
| 76 | RNA polymerase_Homo sapiens_hsa03020 | 0.74350755 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.74091624 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.73802393 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.73325664 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.73302436 |
| 81 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.71631660 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.71108654 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71003360 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70049340 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69976854 |
| 86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69637341 |
| 87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.69108460 |
| 88 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.69086272 |
| 89 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.68719979 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.68570733 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67915468 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65975854 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64697743 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63570520 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62643761 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62570111 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62460908 |
| 98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60427510 |
| 99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60173523 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60091634 |
| 101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60068153 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59741979 |
| 103 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58949802 |
| 104 | RNA degradation_Homo sapiens_hsa03018 | 0.57794710 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57193318 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.56944277 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56340792 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54539063 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54526923 |
| 110 | Taste transduction_Homo sapiens_hsa04742 | 0.53939451 |
| 111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52974827 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.52827093 |
| 113 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50752569 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49883456 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49554593 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49508054 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49437246 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49354542 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.48684277 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48661275 |
| 121 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.46350684 |
| 122 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.45128079 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44473293 |
| 124 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.44387534 |
| 125 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44301320 |
| 126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44121861 |
| 127 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.43292711 |
| 128 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43239420 |
| 129 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42761030 |
| 130 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42688912 |
| 131 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42216451 |
| 132 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41547718 |
| 133 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.39546459 |
| 134 | Renin secretion_Homo sapiens_hsa04924 | 0.39427372 |
| 135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38531767 |
| 136 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38324812 |
| 137 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.36926261 |
| 138 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36382468 |
| 139 | Viral myocarditis_Homo sapiens_hsa05416 | 0.35619873 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.35113743 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35044065 |
| 142 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34970973 |
| 143 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34811602 |
| 144 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.34201957 |
| 145 | Pathways in cancer_Homo sapiens_hsa05200 | 0.33620472 |
| 146 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33614550 |
| 147 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.32215800 |
| 148 | Nicotine addiction_Homo sapiens_hsa05033 | 0.31881180 |
| 149 | Purine metabolism_Homo sapiens_hsa00230 | 0.31634471 |
| 150 | Alcoholism_Homo sapiens_hsa05034 | 0.30856059 |
| 151 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.30567273 |
| 152 | Apoptosis_Homo sapiens_hsa04210 | 0.29799345 |
| 153 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29699120 |
| 154 | Lysosome_Homo sapiens_hsa04142 | 0.29048596 |
| 155 | Measles_Homo sapiens_hsa05162 | 0.29045192 |
| 156 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28864710 |
| 157 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28810340 |
| 158 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28147921 |
| 159 | Hepatitis B_Homo sapiens_hsa05161 | 0.28133528 |
| 160 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.27665003 |
| 161 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.26411055 |
| 162 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.26400489 |
| 163 | Legionellosis_Homo sapiens_hsa05134 | 0.25702191 |
| 164 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.25546325 |
| 165 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.24779892 |
| 166 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24231448 |
| 167 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.23432386 |
| 168 | Adherens junction_Homo sapiens_hsa04520 | 0.23110431 |
| 169 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.21258174 |
| 170 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.20853137 |
| 171 | Basal transcription factors_Homo sapiens_hsa03022 | 0.20451275 |
| 172 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19753632 |
| 173 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19674240 |
| 174 | Influenza A_Homo sapiens_hsa05164 | 0.18048386 |

